11.1 C
New York
Monday, March 4, 2024

scFv biofunctionalized nanoparticles to efficient and protected concentrating on of CEA-expressing colorectal most cancers cells | Journal of Nanobiotechnology


  • Colorectal most cancers. 2020. https://gco.iarc.fr/right now/information/factsheets/cancers/10_8_9-Colorectum-fact-sheet.pdf.

  • Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal most cancers statistics 2023. CA A Most cancers J Clin. 2023;73(3):233–54.

    Article 

    Google Scholar
     

  • Sobral D, Martins M, Kaplan S, Golkaram M, Salmans M, Khan N, et al. Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal most cancers evolution and metastatic improvement. Commun Biol. 2022;5(1):937.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal most cancers. Nat Med. 2015;21(11):1350–6.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Valenzuela G, Canepa J, Simonetti C, Solo de Zaldívar L, Marcelain Okay, González-Montero J. Consensus molecular subtypes of colorectal most cancers in medical observe: a translational method. World J Clin Oncol. 2021;12(11):1000–8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Silveira MJ, Castro F, Oliveira MJ, Sarmento B. Immunomodulatory nanomedicine for colorectal most cancers remedy: a panorama to be explored? Biomater Sci. 2021;9(9):3228–43.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sethy C, Kundu CN. 5-Fluorouracil (5-FU) resistance and the brand new technique to boost the sensitivity in opposition to most cancers: Implication of DNA restore inhibition. Biomed Pharmacother. 2021;137: 111285.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • ten Hoorn S, de Again TR, Sommeijer DW, Vermeulen L. Scientific worth of consensus molecular subtypes in colorectal most cancers: a scientific evaluate and meta-analysis. JNCI J Natl Most cancers Insti. 2021;114(4):503–16.

    Article 

    Google Scholar
     

  • Li Y, Chen Z, Han J, Ma X, Zheng X, Chen J. Useful and therapeutic significance of tumor-associated macrophages in colorectal most cancers. Entrance Oncol. 2022;12: 781233.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang H, Tian T, Zhang J. Tumor-associated macrophages (TAMs) in colorectal most cancers (CRC): from mechanism to remedy and prognosis. Int J Mol Sci. 2021;22(16):8470.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N. 5-Fluorouracil resistance mechanisms in colorectal most cancers: From classical pathways to promising processes. Most cancers Sci. 2020;111(9):3142–54.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kate W, Weng N, Tara Laurine R, Therese MB, Stephanie Hui-Su L, Wei C, et al. Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal most cancers. J Clin Pathol. 2021;74(10):625.

    Article 

    Google Scholar
     

  • Malesci A, Bianchi P, Celesti G, Basso G, Marchesi F, Grizzi F, et al. Tumor-associated macrophages and response to 5-fluorouracil adjuvant remedy in stage III colorectal most cancers. OncoImmunology. 2017;6(12): e1342918.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. M2 macrophages confer resistance to 5-fluorouracil in colorectal most cancers by the activation of CCL22/PI3K/AKT signaling. Onco Targets Ther. 2019;12:3051–63.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Alsaab HO, Alharbi FD, Alhibs AS, Alanazi NB, Alshehri BY, Saleh MA, et al. PLGA-based nanomedicine: historical past of development and improvement in medical purposes of a number of illnesses. Pharmaceutics. 2022;14(12):2728.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Entezar-Almahdi E, Mohammadi-Samani S, Tayebi L, Farjadian F. Latest advances in designing 5-fluorouracil supply programs: a stepping stone within the protected remedy of colorectal most cancers. Int J Nanomedicine. 2020;15:5445–58.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Valencia-Lazcano AA, Hassan D, Pourmadadi M, shamsabadipour A, Behzadmehr R, Rahdar A, et al. 5-Fluorouracil nano-delivery programs as a cutting-edge for most cancers remedy. Eur J Med Chem. 2023;246:114995.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fahmy SA, Mahdy NK, Al Mulla H, ElMeshad AN, Issa MY, Azzazy HME-S. PLGA/PEG nanoparticles loaded with cyclodextrin-peganum harmala alkaloid complicated and ascorbic acid with promising antimicrobial actions. Pharmaceutics. 2022;14(1):142.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chiu HI, Samad NA, Fang L, Lim V. Cytotoxicity of focused PLGA nanoparticles: a scientific evaluate. RSC Adv. 2021;11(16):9433–49.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Aldilaijan AF, Kim YI, Kim CW, Yoon YS, Park IJ, Lim S-B, et al. Scientific implication of tissue carcinoembryonic antigen expression in affiliation with serum carcinoembryonic antigen in colorectal most cancers. Sci Rep. 2023;13(1):7616.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Elekonawo FMK, Bos DL, Goldenberg DM, Boerman OC, Rijpkema M. Carcinoembryonic antigen-targeted photodynamic remedy in colorectal most cancers fashions. EJNMMI Res. 2019;9(1):108.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Vigor KL, Kyrtatos PG, Minogue S, Al-Jamal KT, Kogelberg H, Tolner B, et al. Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of most cancers cells. Biomaterials. 2010;31(6):1307–15.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jin S, Solar Y, Liang X, Gu X, Ning J, Xu Y, et al. Rising new therapeutic antibody derivatives for most cancers remedy. Sign Transduct Goal Ther. 2022;7(1):39.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Graff CP, Chester Okay, Begent R, Wittrup KD. Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37°C. Protein Eng Des Sel. 2004;17(4):293–304.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Begent RHJ, Verhaar MJ, Chester KA, Casey JL, Inexperienced AJ, Napier MP, et al. Scientific proof of environment friendly tumor targetting based mostly on single–chain Fv antibody chosen from a combinatorial library. Nat Med. 1996;2(9):979–84.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Eide PW, Moosavi SH, Eilertsen IA, Brunsell TH, Langerud J, Berg KCG, et al. Metastatic heterogeneity of the consensus molecular subtypes of colorectal most cancers. Npj Genom Med. 2021. https://doi.org/10.1038/s41525-021-00223-7.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cardoso AP, Pinto ML, Pinto AT, Oliveira MI, Pinto MT, Gonçalves R, et al. Macrophages stimulate gastric and colorectal most cancers invasion by EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase exercise. Oncogene. 2014;33(16):2123–33.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • ISO 10993–5: 2009 Organic analysis of medical devices-part 5: assessments for in vitro cytotoxicity ISO: Phoenix, USA 2009. 2007. https://www.iso.org/commonplace/36406.html

  • Lee YC, Boehm MK, Chester KA, Begent RHJ, Perkins SJ. Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J Mol Biol. 2002;320(1):107–27.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang J-L, Du X-J, Yang J-X, Shen S, Li H-J, Luo Y-L, et al. The impact of floor poly(ethylene glycol) size on in vivo drug supply behaviors of polymeric nanoparticles. Biomaterials. 2018;182:104–13.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hoang Thi TT, Pilkington EH, Nguyen DH, Lee JS, Park KD, Truong NP. The significance of poly (ethylene glycol) options for overcoming PEG immunogenicity in drug supply and bioconjugation. Polymers. 2020;12(2):298.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Garizo AR, Castro F, Martins C, Almeida A, Dias TP, Fernardes F, et al. p28-functionalized PLGA nanoparticles loaded with gefitinib cut back tumor burden and metastases formation on lung most cancers. J Management Launch. 2021;337:329–42.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Martins C, Araújo M, Malfanti A, Pacheco C, Smith SJ, Ucakar B, et al. Stimuli-responsive multifunctional nanomedicine for enhanced glioblastoma chemotherapy augments multistage blood-to-brain trafficking and tumor concentrating on. Small. 2023;19(22):2300029.

    Article 
    CAS 

    Google Scholar
     

  • Yuasa N, Koyama T, Subedi GP, Yamaguchi Y, Matsushita M, Fujita-Yamaguchi Y. Expression and structural characterization of anti-T-antigen single-chain antibodies (scFvs) and evaluation of their binding to T-antigen by floor plasmon resonance and NMR spectroscopy. J Biochem. 2013;154(6):521–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Haggag YA, Osman MA, El-Gizawy SA, Goda AE, Shamloula MM, Faheem AM, et al. Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer exercise and ameliorates unwanted side effects in strong Ehrlich carcinoma-bearing mice. Biomed Pharmacother. 2018;105:215–24.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li Q, Li X, Zhao C. Methods to acquire encapsulation and managed launch of small hydrophilic molecules. Entrance Bioeng Biotechnol. 2020. https://doi.org/10.3389/fbioe.2020.00437.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • El-Hammadi MM, Delgado ÁV, Melguizo C, Prados JC, Arias JL. Folic acid-decorated and PEGylated PLGA nanoparticles for bettering the antitumour exercise of 5-fluorouracil. Int J Pharm. 2017;516(1):61–70.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Boehm MK, Corper AL, Wan T, Sohi MK, Sutton BJ, Thornton JD, et al. Crystal construction of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a mannequin for antigen binding based mostly on intermolecular contacts. Biochem J. 2000;346:519–28.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Yoo J, Gained Y-Y. Phenomenology of the preliminary burst launch of medicine from PLGA microparticles. ACS Biomater Sci Eng. 2020;6(11):6053–62.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shao L, Shen S, Liu H. Latest advances in PLGA micro/nanoparticle supply programs as novel therapeutic method for drug-resistant tuberculosis. Entrance Bioeng Biotechnol. 2022. https://doi.org/10.3389/fbioe.2022.941077.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ding D, Zhu Q. Latest advances of PLGA micro/nanoparticles for the supply of biomacromolecular therapeutics. Mater Sci Eng, C Mater Biol Appl. 2018;92:1041–60.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Gonzalez-Exposito R, Semiannikova M, Griffiths B, Khan Okay, Barber LJ, Woolston A, et al. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal most cancers organoids. J Immunother Most cancers. 2019;7(1):101.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tian J, Zhang D, Kurbatov V, Wang Q, Wang Y, Fang D, et al. 5-Fluorouracil efficacy requires anti-tumor immunity triggered by cancer-cell-intrinsic STING. Embo j. 2021;40(7): e106065.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Berg KCG, Eide PW, Eilertsen IA, Johannessen B, Bruun J, Danielsen SA, et al. Multi-omics of 34 colorectal most cancers cell traces – a useful resource for biomedical research. Mol Most cancers. 2017;16(1):116.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bhatia J, Sharma SK, Chester KA, Pedley RB, Boden RW, Learn DA, et al. Catalytic exercise of an in vivo tumor focused anti-CEA scFv::carboxypeptidase G2 fusion protein. Int J Most cancers. 2000;85(4):571–7.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schmidt MM, Thurber GM, Wittrup KD. Kinetics of anti-carcinoembryonic antigen antibody internalization: results of affinity, bivalency, and stability. Most cancers Immunol Immunother. 2008;57(12):1879–90.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ackerman ME, Pawlowski D, Wittrup KD. Impact of antigen turnover price and expression stage on antibody penetration into tumor spheroids. Mol Most cancers Ther. 2008;7(7):2233–40.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shinmi D, Nakano R, Mitamura Okay, Suzuki-Imaizumi M, Iwano J, Isoda Y, et al. Novel anticarcinoembryonic antigen antibody–drug conjugate has antitumor exercise within the existence of soluble antigen. Most cancers Med. 2017;6(4):798–808.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ford CH, Tsaltas GC, Osborne PA, Addetia Okay. Novel circulation cytometric evaluation of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody. Cytometry. 1996;23(3):228–40.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Suetsugu T, Mori R, Futamura M, Fukada M, Tanaka H, Yasufuku I, et al. Mechanism of acquired 5FU resistance and technique for overcoming 5FU resistance specializing in 5FU metabolism in colon most cancers cell traces. Oncol Rep. 2021. https://doi.org/10.3892/or.2021.7978.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Koch J, Mönch D, Maaß A, Gromoll C, Hehr T, Leibold T, et al. Three dimensional cultivation will increase chemo—and radioresistance of colorectal most cancers cell traces. PLoS ONE. 2021;16(1): e0244513.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sakatani A, Sonohara F, Goel A. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil related chemoresistance in colorectal most cancers cells. Carcinogenesis. 2019;40(3):422–31.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Doello Okay, Mesas C, Cabeza L, Gandara MJ, Quiñonero F, Ortiz R. 34P Molecular markers of response to completely different chemotherapeutic brokers in RAS / BRAF mutated colon most cancers cell traces. Ann Oncol. 2020;31:S254–5.

    Article 

    Google Scholar
     

  • Fonseca-Gomes J, Loureiro JA, Tanqueiro SR, Mouro FM, Ruivo P, Carvalho T, et al. In vivo bio-distribution and toxicity analysis of polymeric and lipid-based nanoparticles: a possible method for persistent illnesses remedy. Int J Nanomed. 2020;15:8609–21.

    Article 
    CAS 

    Google Scholar
     

  • Zhang Y, Zhao Y, Li Q, Wang Y. Macrophages, as a promising technique to focused remedy for colorectal most cancers metastasis in tumor immune microenvironment. Entrance Immunol. 2021;12: 685978.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Konstantinov AS, Kovaleva OV, Samoilova DV, Shelekhova KV. Function of macrophages in development of colorectal most cancers: a distinction with the normal paradigm. Int J Clin Exp Pathol. 2022;15(10):403–11.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Related Articles

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Articles